Professor of Medicine (McGill University), hepatologist. Proud Italian mother of 2, speaking 4 languages! I love research, life and positive energy
Montreal, Canada
Joined March 2020
- Tweets466
- Following237
- Followers596
- Likes1.9K
THANK YOU! ❤️🏃♀️A wonderful 10 Km run for a great cause!
So grateful to everyone who supported, donated, and cheered us on!
Every step brings us closer to raising awareness and advancing #liver health.
Together, we are making a difference! 💚
#MASLD
👉 raceroster.com/events/2026/1…
🏆 Honoured to receive #McGill's Department of Medicine Mid-Career Research Award.
Deeply grateful to my family, mentors, colleagues, patients, and research team. ❤️🌱
🏔️“A tourist follows a path; a mountaineer finds one." (R. Messner)
As researchers, we are that mountaineer.
🏃♀️ FUND ME AND OUR DREAM TEAM! ❤️
raceroster.com/events/2026/1…
🌎 Liver disease affects 38% of Canadians and can progress to #cirrhosis & #cancer
💕 Support my 10K & every donation makes a difference! 😊
💯 100% of proceeds go directly to research!
@RIMUHC1 @McGill_DOM @CASLupdates
❤️ Delighted to share our new Review published in @TheLancetHIV
🌍 20–41% have #MASLD
🔬12–20% have significant liver #fibrosis
🚨 It is time to integrate liver health into #HIV care.
#communautéFRQ #Hepatology #LiverHealth #HealthEquity @EACSociety
👉 lnkd.in/gdcqzD62
🎉 Thrilled to share that our team has been awarded a CIHR Project Grant! 🇨🇦
🔬 I'll lead LIFT-IBD (Liver Fibrosis Trajectories in Inflammatory Bowel Disease), a 5-year Canadian multicentre study investigating the intersection of steatotic liver disease, liver fibrosis and #IBD💚
🤖 Made with AI
🚨Proud of our new publication in @HEP_Journal🚨
FIB-4 misses 36% of significant #fibrosis in #HIV (n≈5,000, 7 centers) — worse in #MASLD.
💡 FIB-4 alone isn’t enough.
➡️ Add metabolic + HIV factors (FIB-HIV)
➡️ Consider earlier transient elastography
journals.lww.com/hep/abstrac…
🚨Publication alert🚨
@AGA_GHAdvances
#MASLD in #HIV affects more than the liver, it impacts quality of life.
In our study (n=519), MASLD was linked to worse physical health, fatigue & emotional well-being.
Metabolic burden & fibrosis worsened outcomes.
👉ghadvances.org/article/S2772…
Humbled and honoured to begin my mandate as CASL President 🙏
"The Miracle Worker" has inspired me since childhood as a powerful story of courage, resilience, and hope🌟💪—values that continue to guide me today.
I look forward to working together to advance our shared mission🌍
🤖 Made with AI
Proud to welcome Dr. Giada Sebastiani as the new #CASL President. Her vision: a stronger, more connected Canadian hepatology community across regions, disciplines, and career stages.🤝
Read her full message: hepatology.ca/about-casl/gov…
#Hepatology #CanadianHepatology #Leadership
📢 New paper in @JHEP_Reports👏
Pleased to co-author this global survey on the humanistic & societal burden of #MASH, with outstanding colleagues.
🩺 Advanced fibrosis → worse quality of life
💼 Reduced work productivity
🏥 Higher healthcare utilization
👉jhep-reports.eu/article/S258…
After an intense weekend at the @cddw_clm conference, where I began my mandate as President of #CASL, I relaxed by watching #ThePrestige with my son!
Research can feel like magic🎩
Years of trying, testing, failing, trying again.. until your prestige finally appears! @CASLupdates
🚨Excited to co-author this New publication in @JHEP_Reports🚨
🟠In #MASLD referral pathways, #FIB4 <1.30 may under-triage people with #diabetes or #obesity.
✅These patients should be fast-tracked to #elastography despite a low FIB-4.
@CASLupdates
👉jhep-reports.eu/article/S258…
🚨Proud to co-author this New publication in #Gut🚨
🟠This International Delphi consensus confirms the link between #MASLD and colorectal cancer.
✅Call for earlier, risk-adapted screening and integrated metabolic care.
👉 lnkd.in/gbMdXUG2
#Hepatology #ColorectalCancer
Proud to co-author this Review just published in @LancetGastroHep
🧬We highlight liver health disparities in #transgender and gender diverse populations, review the hepatic safety of modern gender-affirming hormone therapy, and call for inclusive, evidence-based #Hepatology care
Giada Sebastiani retweeted
Calling all Family Physicians! 👩⚕️👨⚕️
Join us virtually on Jan 29 for a program exploring the latest Diabetes Canada & Obesity Canada updates on CKD, MASLD & obesity pharmacotherapy.
💻Live Zoom Webinar
👉Register: imedicus.zoom.us/webinar/reg…
🇨🇦 Big step for liver health in Canada: I was interviewed following Health Canada’s approval of Wegovy® (semaglutide) as pharmacotherapy for #MASH.
This marks an important shift toward recognizing MASH as a complex metabolic disease—beyond lifestyle alone.
healthing.ca/liver-diseases/…
Grateful to be at The #LiverMeeting ✨
🍽️🤝Enjoyed a lovely lunch with colleagues — the kind of conversation that fuels new ideas and reminds me why our community is so special
🎓 Proud to see posters from my talented trainees on display, on #MASLD in #HIV and #IBD📊
#TLM2025
📢 Our Call to Action published in #TheLancetRegionalHealth!
👉#MASLD (fatty liver) affects 1 in 3 adults in the Americas, yet remains missing from Canada’s public health agenda🇨🇦
Time to act with integrated, equitable strategies for #LiverHealth💪
🔗sciencedirect.com/science/ar…
